Cell uptake and oral absorption of titanium dioxide nanoparticles

Toxicology Letters

Volumn 228, Issue 2, 2014, Pages 103-110

  Janer, G ^a   Mas del Molino, E ^a   Fernandez Rosas E ^a   Fernandez A ^a   Vazquez Campos S ^a  

^a LEITAT TECHNOLOGICAL CENTER   (Spain)

Author keywords

Caco 2; ICP MS; Oral bioavailability; TEM; Titanium dioxide nanoparticles

Indexed keywords

TITANIUM DIOXIDE NANOPARTICLE;

ABSORPTION; ARTICLE; CACO 2 CELL LINE; CELL DIFFERENTIATION; CELL TRANSPORT; CELL VIABILITY; COCULTURE; COLORECTAL CARCINOMA; CYTOPLASM VESICLE; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LIMIT OF DETECTION; LIVER; LUNG ALVEOLUS CELL CARCINOMA; MASS SPECTROMETRY; MESENTERY LYMPH NODE; MITOCHONDRION; NONHUMAN; PARTICLE SIZE; PEYER PATCH; PRIORITY JOURNAL; RAT; SMALL INTESTINE; SPLEEN; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY;

CACO-2; ICP-MS; ORAL BIOAVAILABILITY; TEM; TITANIUM DIOXIDE NANOPARTICLES;

ADMINISTRATION, ORAL; ANIMALS; CACO-2 CELLS; HUMANS; INTESTINAL ABSORPTION; MALE; MASS SPECTROMETRY; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; PEYER'S PATCHES; RATS; RATS, SPRAGUE-DAWLEY; TITANIUM;

EID: 84901033730     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.04.014     Document Type: Article

References (52)

1. 2)-sensitive components. Nanotoxicology 2012.
2. Allouni Z.E., Hol P.J., Cauqui M.A., Gjerdet N.R., Cimpan M.R. Role of physicochemical characteristics in the uptake of TiO2 nanoparticles by fibroblasts. Toxicol. In Vitro 2012, 26(3):469-479.
3. 2 and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production. Toxicol. Appl. Pharmacol. 2012, 264(1):94-103.
4. Antunes F., Andrade F., Araujo F., Ferreira D., Sarmento B. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs. Eur. J. Pharm. Biopharm. 2013, 83(3):427-435.
5. Artursson P., Palm K., Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport?. Adv. Drug Deliv. Rev. 2001, 46(1-3):27-43.
6. Baek M., Chung H.E., Yu J., Lee J.A., Kim T.H., Oh J.M., Lee W.J., Paek S.M., Lee J.K., Jeong J., et al. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int. J. Nanomed. 2012, 7:3081-3097.
7. Bu Q., Yan G., Deng P., Peng F., Lin H., Xu Y., Cao Z., Zhou T., Xue A., Wang Y., et al. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnology 2010, 21(12):125105.
8. Cai K., Hou Y., Hu Y., Zhao L., Luo Z., Shi Y., Lai M., Yang W., Liu P. Correlation of the cytotoxicity of TiO2 nanoparticles with different particle sizes on a sub-200-nm scale. Small 2011, 7(21):3026-3031.
9. Crater J.S., Carrier R.L. Barrier properties of gastrointestinal mucus to nanoparticle transport. Macromol. Biosci. 2010, 10(12):1473-1483.
10. EFSA Scientific Committee. 2011. Scientific Opinion on Guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain. EFSA Journal 9(5):2140 [36 pp.]. Available online: http://www.efsa.europa.eu/efsajournal.htm.
11. European Comission, 2006. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Available online: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02006R1907-20130701&qid=1395826642786.
12. Fabian E., Landsiedel R., Ma-Hock L., Wiench K., Wohlleben W., van Ravenzwaay B. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch. Toxicol. 2008, 82(3):151-157.
13. 2 degraded surface-treated nanoparticles: a combined physico-chemical and toxicogenomics approach in caco-2 cells. Part Fibre Toxicol. 2012, 9:18.
14. Florence A.T., Hillery A.M., Hussain N., Jani P.U. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. J. Drug Target 1995, 3(1):65-70.
15. Gerloff K., Pereira D.I., Faria N., Boots A.W., Kolling J., Forster I., Albrecht C., Powell J.J., Schins R.P. Influence of simulated gastrointestinal conditions on particle-induced cytotoxicity and interleukin-8 regulation in differentiated and undifferentiated Caco-2 cells. Nanotoxicology 2013, 7(4):353-366.
16. Gottlieb T.A., Ivanov I.E., Adesnik M., Sabatini D.D. Actin microfilaments play a critical role in endocytosis at the apical but not the basolateral surface of polarized epithelial cells. J. Cell Biol. 1993, 120(3):695-710.
17. Grassi M.G.G., Lapasin R., Colombo I. Understanding Drug Release And Absorption Mechanisms: A Physical And Mathematical Approach 2007, CRC Press.
18. Halamoda Kenzaoui B., Chapuis Bernasconi C., Guney-Ayra S., Juillerat-Jeanneret L. Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells. Biochem. J. 2012, 441(3):813-821.
19. Hilgendorf C., Spahn-Langguth H., Regardh C.G., Lipka E., Amidon G.L., Langguth P. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J. Pharm. Sci. 2000, 89(1):63-75.
20. Hillyer J.F., Albrecht R.M. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J. Pharm. Sci. 2001, 90(12):1927-1936.
21. Hussain S., Thomassen L.C., Ferecatu I., Borot M.C., Andreau K., Martens J.A., Fleury J., Baeza-Squiban A., Marano F., Boland S. Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells. Part Fibre Toxicol. 2010, 7:10.
22. Jackman M.R., Shurety W., Ellis J.A., Luzio J.P. Inhibition of apical but not basolateral endocytosis of ricin and folate in Caco-2 cells by cytochalasin D. J. Cell Sci. 1994, 107(Pt 9):2547-2556.
23. Jaeger A., Weiss D.G., Jonas L., Kriehuber R. Oxidative stress-induced cytotoxic and genotoxic effects of nano-sized titanium dioxide particles in human HaCaT keratinocytes?. Toxicology 2012, 296(1-3):27-36.
24. Jani P.U., McCarthy D.E., Florence A.T. Titanium dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. Int. J. Pharm. 1994, 105:157-168.
25. Jin X., Zhang Z.H., Li S.L., Sun E., Tan X.B., Song J., Jia X.B. A nanostructured liquid crystalline formulation of 20(S)-protopanaxadiol with improved oral absorption. Fitoterapia 2013, 84:64-71.
26. Kavlock R., Chandler K., Houck K., Hunter S., Judson R., Kleinstreuer N., Knudsen T., et al. Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. Chem. Res. Toxicol. 2012, 25(7):1287-1302.
27. Kenzaoui B.H., Vila M.R., Miquel J.M., Cengelli F., Juillerat-Jeanneret L. Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells. Int. J. Nanomed. 2012, 7:1275-1286.
28. Kerneis S., Bogdanova A., Kraehenbuhl J.P., Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 1997, 277(5328):949-952.
29. 2 nanoparticles. Small 2010, 6(17):1908-1917.
30. Koeneman B.A., Zhang Y., Westerhoff P., Chen Y., Crittenden J.C., Capco D.G. Toxicity and cellular responses of intestinal cells exposed to titanium dioxide. Cell Biol. Toxicol. 2010, 26(3):225-238.
31. L'Azou B., Jorly J., On D., Sellier E., Moisan F., Fleury-Feith J., Cambar J., Brochard P., Ohayon-Courtes C. In vitro effects of nanoparticles on renal cells. Part Fibre Toxicol. 2008, 5:22.
32. Landsiedel R., Fabian E., Ma-Hock L., van Ravenzwaay B., Wohlleben W., Wiench K., Oesch F. Toxico-/biokinetics of nanomaterials. Arch. Toxicol. 2012, 86(7):1021-1060.
33. Li C.H., Shen C.C., Cheng Y.W., Huang S.H., Wu C.C., Kao C.C., Liao J.W., Kang J.J. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology 2012, 6(7):746-756.
34. Loo Y., Grigsby C.L., Yamanaka Y.J., Chellappan M.K., Jiang X., Mao H.Q., Leong K.W. Comparative study of nanoparticle-mediated transfection in different GI epithelium co-culture models. J. Control. Release 2012, 160(1):48-56.
35. Mahler G.J., Shuler M.L., Glahn R.P. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability. J. Nutr. Biochem. 2009, 20(7):494-502.
36. Patri A., Umbreit T., Zheng J., Nagashima K., Goering P., Francke-Carroll S., Gordon E., Weaver J., Miller T., Sadrieh N., et al. Energy dispersive x-ray analysis of titanium dioxide nanoparticle distribution after intravenous and subcutaneous injection in mice. J. Appl. Toxicol. 2009, 29(8):662-672.
37. Powell J.J., Faria N., Thomas-McKay E., Pele L.C. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J. Autoimmun. 2010, 34(3):J226-J233.
38. Reix N., Parat A., Seyfritz E., Van der Werf R., Epure V., Ebel N., Danicher L., Marchioni E., Jeandidier N., Pinget M., et al. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles?. Int. J. Pharm. 2012, 437(1-2):213-220.
39. RIPoN2. 2001. Specific advice on fulfilling information requirements for nanomaterials under REACH. Final Project Report.
40. Ruenraroengsak P., Cook J.M., Florence A.T. Nanosystem drug targeting: Facing up to complex realities. J. Control. Release 2010, 141(3):265-276.
41. Schleh C., Semmler-Behnke M., Lipka J., Wenk A., Hirn S., Schaffler M., Schmid G., Simon U., Kreyling W.G. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 2012, 6(1):36-46.
42. 2)) nanoparticles. Nanotoxicology 2013.
43. 2: role of the specific surface area and of surface methylation of the particles. Toxicol. Appl. Pharmacol. 2007, 222(2):141-151.
44. Sonavane G., Tomoda K., Sano A., Ohshima H., Terada H., Makino K. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloid. Surface. B 2008, 65(1):1-10.
45. Sycheva L.P., Zhurkov V.S., Iurchenko V.V., Daugel-Dauge N.O., Kovalenko M.A., Krivtsova E.K., Durnev A.D. Investigation of genotoxic and cytotoxic effects of micro- and nanosized titanium dioxide in six organs of mice in vivo. Mutat. Res. 2011, 726(1):8-14.
46. Torche A.M., Jouan H., Le Corre P., Albina E., Primault R., Jestin A., Le Verge R. Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment. Int. J. Pharm. 2000, 201(1):15-27.
47. van Breemen R.B., Li Y. Caco-2 cell permeability assays to measure drug absorption. Expert Opin. Drug Metab. Toxicol. 2005, 1(2):175-185.
48. Volkheimer G. Persorption of microparticles. Pathologe 1993, 14(5):247-252.
49. Wang J., Zhou G., Chen C., Yu H., Wang T., Ma Y., Jia G., Gao Y., Li B., Sun J., et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 2007, 168(2):176-185.
50. Wang Y., Aker W.G., Hwang H.M., Yedjou C.G., Yu H., Tchounwou P.B. A study of the mechanism of in vitro cytotoxicity of metal oxide nanoparticles using catfish primary hepatocytes and human HepG2 cells. Sci. Total Environ. 2011, 409(22):4753-4762.
51. Warheit D.B., Hansen J.F., Yuen I.S., Kelly D.P., Snajdr S.I., Hartsky M.A. Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation. Toxicol. Appl. Pharmacol. 1997, 145(1):10-22.
52. 2) nanoparticles preferentially induce cell death in transformed cells in a Bak/Bax-independent fashion. PLoS One 2012, 7(11):e50607.